封面
市場調查報告書
商品編碼
2171025

藥物輸送裝置自動化製造與組裝設備市場:全球市場預測,2026-2032年

Drug Delivery Device Automated Manufacturing & Assembly Equipment Market - Global Forecast 2026-2032

出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年,藥物輸送裝置的自動化製造和組裝設備市場將成長至 49.3 億美元,複合年成長率為 8.50%。

主要市場統計數據
基準年 2025 27.8億美元
預計年份:2026年 30.2億美元
預測年份 2032 49.3億美元
複合年成長率 (%) 8.50%

藥物輸送裝置的自動化:概述

用於藥物輸送裝置的自動化製造和組裝設備支援注射器、吸入器、輸液系統和穿戴式給藥平台等產品的可重複生產。該市場的發展受到以下因素的影響:裝置複雜性的不斷提高、對製程控制要求的日益嚴格、複合材料產品應用的不斷成長,以及將組裝流程與檢測、序列化和可追溯性系統相整合的需求。買家越來越傾向於根據設備的檢驗性能、柔軟性、資料完整性、可維護性以及與更廣泛的製造執行環境的整合性來評估設備。

柔軟性和合規性正在重塑我們的生產策略。

製造商正從孤立的、針對特定產品的自動化轉向能夠適應多種規格、組件差異和不斷變化的生產需求的模組化平台。這種轉變反映了產品生命週期縮短、客製化程度提高以及減少換型帶來的中斷的必要性。同時,受監管的生產更加重視文件驗證、統計流程控制、電子記錄和端到端可追溯性。因此,設備設計如今不僅要從速度方面進行評估,還要從可重複性、清潔性、操作人員安全、檢測能力和生命週期支援等方面進行評估。

透過人工智慧 (AI) 增強檢查、維護和流程決策能力

人工智慧 (AI) 在自動化組裝中扮演著日益重要的角色,其應用包括基於機器視覺的檢測、異常檢測、預測性維護、程式參數最佳化和生產調度。其實際價值取決於可靠的感測器資料、具有代表性的訓練資料集、經過驗證的檢驗規則以及清晰的人工監督。在受監管的環境中,製造商必須建立相應的控制系統,以確保模型變更、資料管治、可解釋性、網路安全和可審計性。短期部署最適用於人工智慧輔助現有品質體係而非取代檢驗的放行決策的應用情境。

區域優先事項反映了製造和法規環境的差異。

在北美,重點在於高通量生產、先進檢測、數位化可追溯性以及國內供應鏈的韌性。歐洲則高度重視品質源自於設計(QbD)、永續性、工人保護和監管要求的協調統一,而中東則致力於發展先進的醫療保健製造能力和在地化供給能力。亞太地區將關鍵的電子和精密工程能力與不斷擴大的製藥生產相結合,從而催生了對擴充性和適應性強的自動化設備的需求。拉丁美洲專注於提高本地製造的可靠性和先進設備的獲取,而非洲的情況則更為複雜,投資主要集中在現有的製藥和醫療保健基地。

經濟領域影響標準、投資和供應鏈選擇。

東協支持分散式製造和區域供應鏈一體化,並日益重視設備和服務網路的互通性。金磚國家雖然工業能力和政策重點各不相同,但總體上對本地生產、技術轉移和彈性採購表現出越來越濃厚的興趣。歐盟正在其成員國之間推廣通用的監管和永續性標準。七國集團普遍優先考慮先進的數位製造、高保障水準和網路安全,而海灣合作理事會國家則致力於醫療保健產業的現代化和區域自給自足。北約成員國也日益重視彈性關鍵供應鏈、安全的工業系統以及基本醫療保健產品的持續生產。

每個國家的實際情況都造就了其獨特的自動化需求。

澳洲將嚴格的品質要求與地理位置分散的製造地結合。巴西和墨西哥優先考慮可靠的本地生產、進口容忍度和擴充性的設備支援。加拿大優先考慮受監管的生產以及與先進醫療供應鏈的整合。中國和印度正在擴大其國內藥品和醫療設備的生產能力,同時建構本地自動化生態系統。日本和韓國強調精度、機器人技術和嚴格的流程控制。法國、德國、義大利、西班牙和英國則專注於經過驗證的生產、工程專業化、永續性以及現有工業基礎的現代化。俄羅斯在技術取得和供應鏈連續性方面面臨諸多限制,因此本地支援和靈活的籌資策略變得日益重要。美國在製造高度複雜的複合材料產品、數位化品管系統以及採用先進自動化技術方面仍然是領先的標竿。

優先考慮模組化、檢驗和資料響應式的自動化。

產業領導企業應按產品系列而非單一配置來定義設備需求,充分利用模組化夾具、快速換型和可擴展的檢測架構。檢驗計畫應從設備選用階段開始,涵蓋軟體、資料完整性、網路安全、電子記錄以及與品質系統的整合。企業應優先考慮能夠提供全生命週期服務、持續備件供應、在妥善管理下進行遠距離診斷以及操作員培訓的供應商和內部團隊。人工智慧專案應從缺陷分類和維護警報等有限的用例入手,並輔以已記錄的效能閾值和人工審核。區域採購、雙源規劃和標準化介面可以進一步降低零件短缺和長時間服務中斷的風險。

數據驅動的管理績效評估調查方法

本執行摘要採用明確的市場範圍:用於藥物輸送裝置生產的自動化製造和組裝設備。評估從技術應用、監管和品質要求、製造趨勢、數位化、供應鏈狀況以及區域產業背景等方面對證據進行分類。區域、經濟集團和國家層級的具體觀察結果均來自已建立的公共領域類別,例如藥品和醫療設備法規、製造能力、工業自動化成熟度、貿易韌性以及醫療保健產業政策。本摘要不使用任何市場估算、預測或針對特定公司的聲明,結論僅限於結構性支撐的行業影響。

高度可靠的自動化是維持製造業競爭力的關鍵。

市場正朝著高度互聯、柔軟性且可嚴格驗證的生產系統發展,這些系統能夠支援複雜的藥物輸送裝置,同時滿足嚴格的品質和可追溯性要求。成功的關鍵在於將強大的機械自動化與檢驗的軟體、高品質數據、網路安全、熟練的人員以及可靠的服務網路相結合。領導企業設備視為整合製造和品質架構的一部分,而非僅僅是孤立的投資,則將更有能力應對其全球營運中的產品差異性、監管審查和供應鏈中斷等問題。

目錄

第1章:序言

第2章:調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章:人工智慧的累積影響,2026年

第7章:藥物輸送裝置自動化製造與組裝設備市場:依設備功能分類

  • 組裝設備
    • 組裝設備
    • 子組件裝置
  • 檢驗和測試設備
    • 功能和完整性測試設備
    • 外觀和尺寸檢測設備
  • 零件搬運和供應設備
  • 捲材塗佈加工設備
  • 整合元件封裝和生產線末端設備
  • 單一零件製造設備
  • 整合式藥物填充和分發裝置
  • 標記、貼標和追溯設備

第8章:藥物輸送裝置自動化製造和組裝設備市場:按解決方案標準化分類

  • 客製化系統
  • 可配置平台系統
  • 標準配置系統

第9章:藥物輸送裝置自動化製造與組裝設備市場:依自動化程度分類

  • 全自動系統
  • 半自動系統

第10章:藥物輸送裝置自動化製造與組裝設備市場:依生產架構分類

  • 線性運輸系統
  • 旋轉分度系統
  • 獨立穿梭運輸系統
  • 連續運轉系統
  • 以機器人為中心的組裝單元
  • 卷對卷式捲材系統

第11章:藥物輸送裝置自動化製造與組裝設備市場:依藥物輸送裝置類型分類

  • 腸外注射/輸注裝置
    • 自動噴油器
    • 預填充式注射器和附安全針頭的裝置
    • 筆式注射器
    • 點滴幫浦
    • 體外注射器
    • 無針注射器
  • 肺吸入裝置
    • 定量噴霧吸入器
    • 乾粉吸入器
    • 藥物專用霧化器
    • 緩霧吸入器
  • 經皮和皮內給藥系統
    • 經皮吸收貼片系統
    • 微針輸送系統
  • 鼻腔給藥裝置
    • 多劑量鼻噴霧
    • 用於單劑量和雙劑量的鼻腔給藥裝置
  • 眼科配藥器
  • 口服液體給藥裝置

第12章:藥物輸送裝置的自動化製造和組裝設備市場:依買方角色分類

  • 製藥和生物技術製造商
  • 契約製造和CDMO
  • 藥物輸送裝置製造商
  • 設備組件和主容器製造商

第13章:藥物輸送裝置自動化製造與組裝設備市場:依生產生命週期階段分類

  • 商業生產系統
  • 臨床和驗證系統
  • 開發和可行性評估系統

第14章:藥物輸送裝置自動化製造與組裝設備市場:依生產線整合

  • 承包生產線
  • 整合製程單元
  • 獨立設備

第15章:藥物輸送裝置自動化製造和組裝設備市場:依藥物和醫療設備組成分類

  • 單組分藥品和醫療設備複雜產品
  • 用於藥品和醫療設備的複方包裝產品
  • 藥品和醫療設備分開供應的系統。

第16章:藥物輸送裝置的自動化製造和組裝設備市場:按形式彈性分類

  • 可互換部件多格式系統
  • 專用格式化系統
  • 模組化、可重構系統

第17章:藥物輸送裝置自動化製造與組裝設備市場:依地區分類

  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東
  • 非洲

第18章:藥物輸送裝置自動化製造與組裝設備市場:依組別分類

  • NATO
  • G7
  • EU
  • BRICS
  • ASEAN
  • GCC

第19章:藥物輸送裝置自動化製造與組裝設備市場:依國家分類

  • 美國
  • 中國
  • 德國
  • 日本
  • 義大利
  • 印度
  • 法國
  • 英國
  • 加拿大
  • 巴西
  • 韓國
  • 西班牙
  • 墨西哥
  • 澳洲
  • 俄羅斯

第20章 競爭格局

  • 2025年市佔率分析
  • 市場集中度分析,2025年
    • 濃度比(CR)
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析,2025 年
  • 2025年產品系列分析
  • 基準分析,2025 年

第21章 公司簡介

  • ATS Corporation
  • Syntegon Technology GmbH
  • IMA Group
  • Stevanato Group SpA
  • Harro Hofliger
  • Mikron Group
  • BBS Automation
  • PIA Automation Holding GmbH
  • groninger group
  • MA micro automation GmbH
  • Coesia SpA
  • HAHN Automation Group
  • Haumiller Engineering
  • The Arthur G. Russell Company
  • ZAHORANSKY Automation & Molds GmbH
  • Neyret Group
  • SHL Advantec
  • Tofflon Science and Technology Group Co., Ltd.
  • Truking Technology Limited
  • Snowbell Machines Pvt. Ltd.
  • Allpharm Technologies Pvt Ltd
  • Musashino Sekkei Kogyo Co., Ltd.
  • SP Automation & Robotics
  • ESSERT GmbH
  • Sytec srl
  • ATC Automation
  • TurboFil Packaging Machines, LLC
  • Orientech Automation Solutions
  • Rychiger AG
  • 3P innovation Ltd
  • Integrated Mechanization Solutions BV
  • GTE Engineering
  • Lambert Automation Limited
  • Bausch+Strobel SE+Co. KG
  • Marchesini Group
  • Korber Pharma
  • Delta ModTech
  • RCA Bignami GmbH
  • Hanbury-Autogil Ltd
  • Astech Projects Ltd

第22章 主要專家

Product Code: MRR-0E5C8F7B31DB

The Drug Delivery Device Automated Manufacturing & Assembly Equipment Market is projected to grow by USD 4.93 billion at a CAGR of 8.50% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.78 billion
Estimated Year [2026] USD 3.02 billion
Forecast Year [2032] USD 4.93 billion
CAGR (%) 8.50%

Drug Delivery Device Automation: Executive Overview

Automated manufacturing and assembly equipment for drug delivery devices supports the repeatable production of products such as injectors, inhalation devices, infusion systems, and wearable delivery platforms. The market is shaped by rising device complexity, tighter requirements for process control, increased use of combination products, and the need to connect assembly operations with inspection, serialization, and traceability systems. Buyers increasingly assess equipment on validated performance, flexibility, data integrity, maintainability, and integration with broader manufacturing execution environments.

Flexibility and Compliance Are Reshaping Production Strategies

Manufacturers are moving from isolated, product-specific automation toward modular platforms that can accommodate multiple formats, component variants, and changing production requirements. This shift reflects shorter product life cycles, growing customization, and the need to reduce changeover disruption. At the same time, regulated production places greater emphasis on documented validation, statistical process control, electronic records, and end-to-end traceability. Equipment design is therefore being evaluated not only for speed, but also for repeatability, cleanability, operator safety, inspection capability, and lifecycle support.

Artificial Intelligence Strengthens Inspection, Maintenance, and Process Decisions

Artificial intelligence is increasingly relevant to automated assembly through machine-vision inspection, anomaly detection, predictive maintenance, process-parameter optimization, and production scheduling. Its practical value depends on reliable sensor data, representative training datasets, validated decision rules, and clear human oversight. In regulated environments, manufacturers must establish controls for model changes, data governance, explainability, cybersecurity, and auditability. Near-term adoption is most credible in applications where AI assists established quality systems rather than replacing validated release decisions.

Regional Priorities Reflect Different Manufacturing and Regulatory Conditions

North America emphasizes high-throughput production, advanced inspection, digital traceability, and domestic supply-chain resilience. Europe places strong weight on quality-by-design, sustainability, worker protection, and harmonized regulatory expectations, while the Middle East is developing advanced healthcare manufacturing capacity and localized supply capabilities. Asia-Pacific combines major electronics and precision-engineering capabilities with expanding pharmaceutical production, creating demand for scalable and adaptable automation. Latin America is focused on improving local manufacturing reliability and access to sophisticated equipment, while Africa presents a more uneven landscape in which investment is concentrated around established pharmaceutical and healthcare hubs.

Economic Blocs Influence Standards, Investment, and Supply-Chain Choices

ASEAN supports distributed manufacturing and regional supply-chain integration, increasing the importance of interoperable equipment and service networks. BRICS economies reflect varied industrial capabilities and policy priorities, but collectively reinforce interest in local production, technology transfer, and resilient sourcing. The European Union promotes common regulatory and sustainability expectations across member states. G7 markets generally prioritize advanced digital manufacturing, high assurance, and cybersecurity, while GCC countries are investing in healthcare industrialization and regional self-sufficiency. NATO members also place growing emphasis on resilient critical supply chains, secure industrial systems, and continuity of essential medical production.

Country Conditions Create Distinct Automation Requirements

Australia combines stringent quality expectations with a geographically dispersed manufacturing base. Brazil and Mexico emphasize dependable local production, import resilience, and scalable equipment support. Canada prioritizes regulated manufacturing and integration with advanced healthcare supply chains. China and India are expanding domestic pharmaceutical and device capabilities while developing local automation ecosystems. Japan and South Korea emphasize precision, robotics, and disciplined process control. France, Germany, Italy, Spain, and the United Kingdom focus on validated production, engineering specialization, sustainability, and modernization of established industrial bases. Russia faces constraints related to technology access and supply-chain continuity, increasing the importance of local support and adaptable sourcing strategies. The United States remains a major reference point for high-complexity combination-product manufacturing, digital quality systems, and advanced automation deployment.

Prioritize Modular, Validated, and Data-Ready Automation

Industry leaders should define equipment requirements around product families rather than a single configuration, using modular tooling, rapid changeover, and scalable inspection architecture. Validation planning should begin during equipment selection and cover software, data integrity, cybersecurity, electronic records, and integration with quality systems. Organizations should prioritize suppliers and internal teams that can provide lifecycle service, spare-parts continuity, remote diagnostics with appropriate controls, and operator training. AI initiatives should begin with bounded use cases such as defect classification or maintenance alerts, supported by documented performance thresholds and human review. Regional sourcing, dual-source planning, and standardized interfaces can further reduce exposure to component shortages and long service interruptions.

Methodology for a Data-Backed Executive Assessment

This executive summary uses the defined market scope of automated manufacturing and assembly equipment serving drug delivery device production. The assessment organizes evidence by technology adoption, regulatory and quality requirements, manufacturing trends, digitalization, supply-chain conditions, and geographic industrial context. Regional, economic-group, and country observations are synthesized from established public-domain categories of pharmaceutical and medical-device regulation, manufacturing capability, industrial automation maturity, trade resilience, and healthcare industrial policy. No market estimates, market shares, forecasts, or company-specific claims are used; conclusions are limited to structurally supported industry implications.

Reliable Automation Will Define Competitive Manufacturing Capability

The market is progressing toward connected, flexible, inspection-rich production systems that can support complex drug delivery devices while meeting demanding quality and traceability requirements. Success will depend on combining robust mechanical automation with validated software, high-quality data, cybersecurity, skilled personnel, and resilient service networks. Leaders that treat equipment as part of an integrated manufacturing and quality architecture-not as a standalone capital purchase-will be better positioned to manage product variation, regulatory scrutiny, and supply-chain disruption across global operations.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. New Revenue Opportunities
  • 3.4. Next-Generation Business Models
  • 3.5. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
      • 4.3.1.1. Expansion of Injectable and Self-Administration Capacity
      • 4.3.1.2. Rising Quality-Control and Regulatory Expectations
      • 4.3.1.3. Growth of Outsourced Multi-Client Manufacturing
      • 4.3.1.4. Higher Automation and Process Integration
    • 4.3.2. Key Restraints
      • 4.3.2.1. High Capital Commitment and Validation Burden
      • 4.3.2.2. Device-Specific Engineering and Format Lock-In
      • 4.3.2.3. Approval and Project-Timing Uncertainty
      • 4.3.2.4. Long Equipment Life and Retrofit Substitution
    • 4.3.3. Key Opportunities
      • 4.3.3.1. Configurable Clinical-to-Commercial Platforms
      • 4.3.3.2. Inspection, Traceability, and Line Modernization
      • 4.3.3.3. Automation for Emerging Delivery Formats
      • 4.3.3.4. Flexible Ownership and Equipment-as-a-Service
      • 4.3.3.5. Regional Manufacturing and Service Localization
    • 4.3.4. Key Challenges
      • 4.3.4.1. Preserving Product Performance During Scale-Up
      • 4.3.4.2. Component Variability and Reliable Feeding
      • 4.3.4.3. Digital Interoperability and Data Integrity
      • 4.3.4.4. Scaling Qualified Global Service Coverage
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Drug Delivery Device Automated Manufacturing & Assembly Equipment Market, by Equipment Function

  • 7.1. Introduction
  • 7.2. Assembly Equipment
    • 7.2.1. Final Assembly Equipment
    • 7.2.2. Subassembly Equipment
  • 7.3. Inspection & Testing Equipment
    • 7.3.1. Functional & Integrity Testing Equipment
    • 7.3.2. Visual & Dimensional Inspection Equipment
  • 7.4. Component Handling & Feeding Equipment
  • 7.5. Web Coating & Converting Equipment
  • 7.6. Integrated Device Packaging & End-of-Line Equipment
  • 7.7. Discrete Component Fabrication Equipment
  • 7.8. Integrated Drug Filling & Dosing Equipment
  • 7.9. Marking, Labeling & Traceability Equipment

8. Drug Delivery Device Automated Manufacturing & Assembly Equipment Market, by Solution Standardization

  • 8.1. Introduction
  • 8.2. Custom-Engineered Systems
  • 8.3. Configurable Platform Systems
  • 8.4. Standard-Configuration Systems

9. Drug Delivery Device Automated Manufacturing & Assembly Equipment Market, by Automation Level

  • 9.1. Introduction
  • 9.2. Fully Automated Systems
  • 9.3. Semi-Automated Systems

10. Drug Delivery Device Automated Manufacturing & Assembly Equipment Market, by Production Architecture

  • 10.1. Introduction
  • 10.2. Linear Transfer Systems
  • 10.3. Rotary Indexing Systems
  • 10.4. Independent-Shuttle Transport Systems
  • 10.5. Continuous-Motion Systems
  • 10.6. Robot-Centric Assembly Cells
  • 10.7. Roll-to-Roll Web Systems

11. Drug Delivery Device Automated Manufacturing & Assembly Equipment Market, by Drug Delivery Device Type

  • 11.1. Introduction
  • 11.2. Parenteral Injection & Infusion Devices
    • 11.2.1. Autoinjectors
    • 11.2.2. Prefilled Syringes & Needle-Safety Devices
    • 11.2.3. Pen Injectors
    • 11.2.4. Drug-Specific Infusion Pumps
    • 11.2.5. On-Body Injectors
    • 11.2.6. Needle-Free Injectors
  • 11.3. Pulmonary Inhalation Devices
    • 11.3.1. Metered-Dose Inhalers
    • 11.3.2. Dry-Powder Inhalers
    • 11.3.3. Drug-Specific Nebulizers
    • 11.3.4. Soft-Mist Inhalers
  • 11.4. Transdermal & Intradermal Delivery Systems
    • 11.4.1. Transdermal Patch Systems
    • 11.4.2. Microneedle Delivery Systems
  • 11.5. Nasal Delivery Devices
    • 11.5.1. Multidose Nasal Spray Devices
    • 11.5.2. Unit- & Bi-Dose Nasal Devices
  • 11.6. Ophthalmic Dispensers
  • 11.7. Oral Liquid Dosing Devices

12. Drug Delivery Device Automated Manufacturing & Assembly Equipment Market, by Buyer Role

  • 12.1. Introduction
  • 12.2. Pharmaceutical & Biotechnology Manufacturers
  • 12.3. Contract Manufacturers & CDMOs
  • 12.4. Drug Delivery Device Manufacturers
  • 12.5. Device Component & Primary-Container Manufacturers

13. Drug Delivery Device Automated Manufacturing & Assembly Equipment Market, by Production Lifecycle Stage

  • 13.1. Introduction
  • 13.2. Commercial Production Systems
  • 13.3. Clinical & Validation Systems
  • 13.4. Development & Feasibility Systems

14. Drug Delivery Device Automated Manufacturing & Assembly Equipment Market, by Line Integration

  • 14.1. Introduction
  • 14.2. Turnkey Production Lines
  • 14.3. Integrated Process Cells
  • 14.4. Standalone Machines

15. Drug Delivery Device Automated Manufacturing & Assembly Equipment Market, by Drug-Device Configuration

  • 15.1. Introduction
  • 15.2. Single-Entity Drug-Device Products
  • 15.3. Co-Packaged Drug-Device Products
  • 15.4. Separately Supplied Drug-Device Systems

16. Drug Delivery Device Automated Manufacturing & Assembly Equipment Market, by Format Flexibility

  • 16.1. Introduction
  • 16.2. Change-Part Multi-Format Systems
  • 16.3. Dedicated-Format Systems
  • 16.4. Modular Reconfigurable Systems

17. Drug Delivery Device Automated Manufacturing & Assembly Equipment Market, by Region

  • 17.1. Introduction
  • 17.2. North America
  • 17.3. Europe
  • 17.4. Asia-Pacific
  • 17.5. Latin America
  • 17.6. Middle East
  • 17.7. Africa

18. Drug Delivery Device Automated Manufacturing & Assembly Equipment Market, by Group

  • 18.1. Introduction
  • 18.2. NATO
  • 18.3. G7
  • 18.4. European Union
  • 18.5. BRICS
  • 18.6. ASEAN
  • 18.7. GCC

19. Drug Delivery Device Automated Manufacturing & Assembly Equipment Market, by Country

  • 19.1. Introduction
  • 19.2. United States
  • 19.3. China
  • 19.4. Germany
  • 19.5. Japan
  • 19.6. Italy
  • 19.7. India
  • 19.8. France
  • 19.9. United Kingdom
  • 19.10. Canada
  • 19.11. Brazil
  • 19.12. South Korea
  • 19.13. Spain
  • 19.14. Mexico
  • 19.15. Australia
  • 19.16. Russia

20. Competitive Landscape

  • 20.1. Market Share Analysis, 2025
  • 20.2. Market Concentration Analysis, 2025
    • 20.2.1. Concentration Ratio (CR)
    • 20.2.2. Herfindahl Hirschman Index (HHI)
  • 20.3. Recent Developments & Impact Analysis, 2025
  • 20.4. Product Portfolio Analysis, 2025
  • 20.5. Benchmarking Analysis, 2025

21. Company Profiles

  • 21.1. ATS Corporation
  • 21.2. Syntegon Technology GmbH
  • 21.3. IMA Group
  • 21.4. Stevanato Group S.p.A.
  • 21.5. Harro Hofliger
  • 21.6. Mikron Group
  • 21.7. BBS Automation
  • 21.8. PIA Automation Holding GmbH
  • 21.9. groninger group
  • 21.10. MA micro automation GmbH
  • 21.11. Coesia S.p.A.
  • 21.12. HAHN Automation Group
  • 21.13. Haumiller Engineering
  • 21.14. The Arthur G. Russell Company
  • 21.15. ZAHORANSKY Automation & Molds GmbH
  • 21.16. Neyret Group
  • 21.17. SHL Advantec
  • 21.18. Tofflon Science and Technology Group Co., Ltd.
  • 21.19. Truking Technology Limited
  • 21.20. Snowbell Machines Pvt. Ltd.
  • 21.21. Allpharm Technologies Pvt Ltd
  • 21.22. Musashino Sekkei Kogyo Co., Ltd.
  • 21.23. SP Automation & Robotics
  • 21.24. ESSERT GmbH
  • 21.25. Sytec srl
  • 21.26. ATC Automation
  • 21.27. TurboFil Packaging Machines, LLC
  • 21.28. Orientech Automation Solutions
  • 21.29. Rychiger AG
  • 21.30. 3P innovation Ltd
  • 21.31. Integrated Mechanization Solutions BV
  • 21.32. GTE Engineering
  • 21.33. Lambert Automation Limited
  • 21.34. Bausch+Strobel SE + Co. KG
  • 21.35. Marchesini Group
  • 21.36. Korber Pharma
  • 21.37. Delta ModTech
  • 21.38. RCA Bignami GmbH
  • 21.39. Hanbury-Autogil Ltd
  • 21.40. Astech Projects Ltd

22. Key Experts

LIST OF FIGURES

  • FIGURE 1. Global Drug Delivery Device Automated Manufacturing & Assembly Equipment Market, Years Considered for the Study
  • FIGURE 2. Global Drug Delivery Device Automated Manufacturing & Assembly Equipment Market, Research Design
  • FIGURE 3. Global Drug Delivery Device Automated Manufacturing & Assembly Equipment Market, Research Framework
  • FIGURE 4. Global Drug Delivery Device Automated Manufacturing & Assembly Equipment Market, Data Triangulation
  • FIGURE 5. Global Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, 2017-2032 (USD Million)
  • FIGURE 6. Global Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Equipment Function, 2025 vs 2032 (%)
  • FIGURE 7. Global Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Equipment Function, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 8. Global Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Solution Standardization, 2025 vs 2032 (%)
  • FIGURE 9. Global Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Solution Standardization, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 10. Global Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Automation Level, 2025 vs 2032 (%)
  • FIGURE 11. Global Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Automation Level, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 12. Global Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Production Architecture, 2025 vs 2032 (%)
  • FIGURE 13. Global Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Production Architecture, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 14. Global Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Drug Delivery Device Type, 2025 vs 2032 (%)
  • FIGURE 15. Global Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Drug Delivery Device Type, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 16. Global Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Buyer Role, 2025 vs 2032 (%)
  • FIGURE 17. Global Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Buyer Role, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 18. Global Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Production Lifecycle Stage, 2025 vs 2032 (%)
  • FIGURE 19. Global Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Production Lifecycle Stage, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 20. Global Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Line Integration, 2025 vs 2032 (%)
  • FIGURE 21. Global Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Line Integration, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 22. Global Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Drug-Device Configuration, 2025 vs 2032 (%)
  • FIGURE 23. Global Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Drug-Device Configuration, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 24. Global Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Format Flexibility, 2025 vs 2032 (%)
  • FIGURE 25. Global Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Format Flexibility, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 26. Global Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Region, 2025 vs 2032 (%)
  • FIGURE 27. Global Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 28. Global Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 29. Global Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Country, 2025 vs 2032 (%)
  • FIGURE 30. Global Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 31. Global Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Share, by Key Player, 2025

LIST OF TABLES

  • TABLE 1. Global Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Segmentation & Coverage
  • TABLE 2. Global Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, 2017-2032 (USD Million)
  • TABLE 3. Global Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Equipment Function, 2017-2032 (USD Million)
  • TABLE 4. Global Assembly Equipment Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 5. Global Assembly Equipment Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 6. Global Assembly Equipment Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 7. Global Final Assembly Equipment Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 8. Global Final Assembly Equipment Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 9. Global Final Assembly Equipment Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 10. Global Subassembly Equipment Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 11. Global Subassembly Equipment Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 12. Global Subassembly Equipment Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 13. Global Inspection & Testing Equipment Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 14. Global Inspection & Testing Equipment Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 15. Global Inspection & Testing Equipment Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 16. Global Functional & Integrity Testing Equipment Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 17. Global Functional & Integrity Testing Equipment Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 18. Global Functional & Integrity Testing Equipment Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 19. Global Visual & Dimensional Inspection Equipment Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 20. Global Visual & Dimensional Inspection Equipment Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 21. Global Visual & Dimensional Inspection Equipment Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 22. Global Component Handling & Feeding Equipment Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 23. Global Component Handling & Feeding Equipment Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 24. Global Component Handling & Feeding Equipment Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 25. Global Web Coating & Converting Equipment Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 26. Global Web Coating & Converting Equipment Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 27. Global Web Coating & Converting Equipment Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 28. Global Integrated Device Packaging & End-of-Line Equipment Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 29. Global Integrated Device Packaging & End-of-Line Equipment Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 30. Global Integrated Device Packaging & End-of-Line Equipment Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 31. Global Discrete Component Fabrication Equipment Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 32. Global Discrete Component Fabrication Equipment Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 33. Global Discrete Component Fabrication Equipment Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 34. Global Integrated Drug Filling & Dosing Equipment Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 35. Global Integrated Drug Filling & Dosing Equipment Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 36. Global Integrated Drug Filling & Dosing Equipment Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 37. Global Marking, Labeling & Traceability Equipment Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 38. Global Marking, Labeling & Traceability Equipment Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 39. Global Marking, Labeling & Traceability Equipment Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 40. Global Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Solution Standardization, 2017-2032 (USD Million)
  • TABLE 41. Global Custom-Engineered Systems Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 42. Global Custom-Engineered Systems Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 43. Global Custom-Engineered Systems Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 44. Global Configurable Platform Systems Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 45. Global Configurable Platform Systems Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 46. Global Configurable Platform Systems Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 47. Global Standard-Configuration Systems Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 48. Global Standard-Configuration Systems Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 49. Global Standard-Configuration Systems Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 50. Global Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Automation Level, 2017-2032 (USD Million)
  • TABLE 51. Global Fully Automated Systems Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 52. Global Fully Automated Systems Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 53. Global Fully Automated Systems Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 54. Global Semi-Automated Systems Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 55. Global Semi-Automated Systems Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 56. Global Semi-Automated Systems Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 57. Global Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Production Architecture, 2017-2032 (USD Million)
  • TABLE 58. Global Linear Transfer Systems Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 59. Global Linear Transfer Systems Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 60. Global Linear Transfer Systems Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 61. Global Rotary Indexing Systems Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 62. Global Rotary Indexing Systems Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 63. Global Rotary Indexing Systems Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 64. Global Independent-Shuttle Transport Systems Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 65. Global Independent-Shuttle Transport Systems Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 66. Global Independent-Shuttle Transport Systems Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 67. Global Continuous-Motion Systems Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 68. Global Continuous-Motion Systems Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 69. Global Continuous-Motion Systems Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 70. Global Robot-Centric Assembly Cells Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 71. Global Robot-Centric Assembly Cells Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 72. Global Robot-Centric Assembly Cells Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 73. Global Roll-to-Roll Web Systems Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 74. Global Roll-to-Roll Web Systems Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 75. Global Roll-to-Roll Web Systems Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 76. Global Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Drug Delivery Device Type, 2017-2032 (USD Million)
  • TABLE 77. Global Parenteral Injection & Infusion Devices Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 78. Global Parenteral Injection & Infusion Devices Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 79. Global Parenteral Injection & Infusion Devices Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 80. Global Autoinjectors Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 81. Global Autoinjectors Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 82. Global Autoinjectors Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 83. Global Prefilled Syringes & Needle-Safety Devices Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 84. Global Prefilled Syringes & Needle-Safety Devices Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 85. Global Prefilled Syringes & Needle-Safety Devices Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 86. Global Pen Injectors Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 87. Global Pen Injectors Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 88. Global Pen Injectors Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 89. Global Drug-Specific Infusion Pumps Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 90. Global Drug-Specific Infusion Pumps Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 91. Global Drug-Specific Infusion Pumps Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 92. Global On-Body Injectors Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 93. Global On-Body Injectors Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 94. Global On-Body Injectors Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 95. Global Needle-Free Injectors Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 96. Global Needle-Free Injectors Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 97. Global Needle-Free Injectors Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 98. Global Pulmonary Inhalation Devices Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 99. Global Pulmonary Inhalation Devices Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 100. Global Pulmonary Inhalation Devices Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 101. Global Metered-Dose Inhalers Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 102. Global Metered-Dose Inhalers Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 103. Global Metered-Dose Inhalers Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 104. Global Dry-Powder Inhalers Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 105. Global Dry-Powder Inhalers Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 106. Global Dry-Powder Inhalers Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 107. Global Drug-Specific Nebulizers Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 108. Global Drug-Specific Nebulizers Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 109. Global Drug-Specific Nebulizers Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 110. Global Soft-Mist Inhalers Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 111. Global Soft-Mist Inhalers Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 112. Global Soft-Mist Inhalers Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 113. Global Transdermal & Intradermal Delivery Systems Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 114. Global Transdermal & Intradermal Delivery Systems Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 115. Global Transdermal & Intradermal Delivery Systems Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 116. Global Transdermal Patch Systems Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 117. Global Transdermal Patch Systems Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 118. Global Transdermal Patch Systems Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 119. Global Microneedle Delivery Systems Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 120. Global Microneedle Delivery Systems Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 121. Global Microneedle Delivery Systems Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 122. Global Nasal Delivery Devices Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 123. Global Nasal Delivery Devices Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 124. Global Nasal Delivery Devices Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 125. Global Multidose Nasal Spray Devices Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 126. Global Multidose Nasal Spray Devices Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 127. Global Multidose Nasal Spray Devices Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 128. Global Unit- & Bi-Dose Nasal Devices Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 129. Global Unit- & Bi-Dose Nasal Devices Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 130. Global Unit- & Bi-Dose Nasal Devices Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 131. Global Ophthalmic Dispensers Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 132. Global Ophthalmic Dispensers Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 133. Global Ophthalmic Dispensers Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 134. Global Oral Liquid Dosing Devices Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 135. Global Oral Liquid Dosing Devices Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 136. Global Oral Liquid Dosing Devices Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 137. Global Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Buyer Role, 2017-2032 (USD Million)
  • TABLE 138. Global Pharmaceutical & Biotechnology Manufacturers Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 139. Global Pharmaceutical & Biotechnology Manufacturers Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 140. Global Pharmaceutical & Biotechnology Manufacturers Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 141. Global Contract Manufacturers & CDMOs Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 142. Global Contract Manufacturers & CDMOs Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 143. Global Contract Manufacturers & CDMOs Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 144. Global Drug Delivery Device Manufacturers Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 145. Global Drug Delivery Device Manufacturers Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 146. Global Drug Delivery Device Manufacturers Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 147. Global Device Component & Primary-Container Manufacturers Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 148. Global Device Component & Primary-Container Manufacturers Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 149. Global Device Component & Primary-Container Manufacturers Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 150. Global Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Production Lifecycle Stage, 2017-2032 (USD Million)
  • TABLE 151. Global Commercial Production Systems Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 152. Global Commercial Production Systems Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 153. Global Commercial Production Systems Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 154. Global Clinical & Validation Systems Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 155. Global Clinical & Validation Systems Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 156. Global Clinical & Validation Systems Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 157. Global Development & Feasibility Systems Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 158. Global Development & Feasibility Systems Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 159. Global Development & Feasibility Systems Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 160. Global Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Line Integration, 2017-2032 (USD Million)
  • TABLE 161. Global Turnkey Production Lines Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 162. Global Turnkey Production Lines Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 163. Global Turnkey Production Lines Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 164. Global Integrated Process Cells Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 165. Global Integrated Process Cells Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 166. Global Integrated Process Cells Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 167. Global Standalone Machines Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 168. Global Standalone Machines Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 169. Global Standalone Machines Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 170. Global Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Drug-Device Configuration, 2017-2032 (USD Million)
  • TABLE 171. Global Single-Entity Drug-Device Products Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 172. Global Single-Entity Drug-Device Products Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 173. Global Single-Entity Drug-Device Products Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 174. Global Co-Packaged Drug-Device Products Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 175. Global Co-Packaged Drug-Device Products Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 176. Global Co-Packaged Drug-Device Products Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 177. Global Separately Supplied Drug-Device Systems Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 178. Global Separately Supplied Drug-Device Systems Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 179. Global Separately Supplied Drug-Device Systems Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 180. Global Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Format Flexibility, 2017-2032 (USD Million)
  • TABLE 181. Global Change-Part Multi-Format Systems Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 182. Global Change-Part Multi-Format Systems Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 183. Global Change-Part Multi-Format Systems Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 184. Global Dedicated-Format Systems Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 185. Global Dedicated-Format Systems Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 186. Global Dedicated-Format Systems Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 187. Global Modular Reconfigurable Systems Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 188. Global Modular Reconfigurable Systems Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 189. Global Modular Reconfigurable Systems Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 190. Global Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 191. North America Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 192. North America Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Equipment Function, 2017-2032 (USD Million)
  • TABLE 193. North America Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Assembly Equipment, 2017-2032 (USD Million)
  • TABLE 194. North America Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Inspection & Testing Equipment, 2017-2032 (USD Million)
  • TABLE 195. North America Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Solution Standardization, 2017-2032 (USD Million)
  • TABLE 196. North America Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Automation Level, 2017-2032 (USD Million)
  • TABLE 197. North America Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Production Architecture, 2017-2032 (USD Million)
  • TABLE 198. North America Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Drug Delivery Device Type, 2017-2032 (USD Million)
  • TABLE 199. North America Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Parenteral Injection & Infusion Devices, 2017-2032 (USD Million)
  • TABLE 200. North America Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Pulmonary Inhalation Devices, 2017-2032 (USD Million)
  • TABLE 201. North America Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Transdermal & Intradermal Delivery Systems, 2017-2032 (USD Million)
  • TABLE 202. North America Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Nasal Delivery Devices, 2017-2032 (USD Million)
  • TABLE 203. North America Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Buyer Role, 2017-2032 (USD Million)
  • TABLE 204. North America Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Production Lifecycle Stage, 2017-2032 (USD Million)
  • TABLE 205. North America Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Line Integration, 2017-2032 (USD Million)
  • TABLE 206. North America Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Drug-Device Configuration, 2017-2032 (USD Million)
  • TABLE 207. North America Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Format Flexibility, 2017-2032 (USD Million)
  • TABLE 208. Europe Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 209. Europe Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Equipment Function, 2017-2032 (USD Million)
  • TABLE 210. Europe Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Assembly Equipment, 2017-2032 (USD Million)
  • TABLE 211. Europe Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Inspection & Testing Equipment, 2017-2032 (USD Million)
  • TABLE 212. Europe Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Solution Standardization, 2017-2032 (USD Million)
  • TABLE 213. Europe Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Automation Level, 2017-2032 (USD Million)
  • TABLE 214. Europe Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Production Architecture, 2017-2032 (USD Million)
  • TABLE 215. Europe Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Drug Delivery Device Type, 2017-2032 (USD Million)
  • TABLE 216. Europe Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Parenteral Injection & Infusion Devices, 2017-2032 (USD Million)
  • TABLE 217. Europe Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Pulmonary Inhalation Devices, 2017-2032 (USD Million)
  • TABLE 218. Europe Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Transdermal & Intradermal Delivery Systems, 2017-2032 (USD Million)
  • TABLE 219. Europe Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Nasal Delivery Devices, 2017-2032 (USD Million)
  • TABLE 220. Europe Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Buyer Role, 2017-2032 (USD Million)
  • TABLE 221. Europe Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Production Lifecycle Stage, 2017-2032 (USD Million)
  • TABLE 222. Europe Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Line Integration, 2017-2032 (USD Million)
  • TABLE 223. Europe Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Drug-Device Configuration, 2017-2032 (USD Million)
  • TABLE 224. Europe Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Format Flexibility, 2017-2032 (USD Million)
  • TABLE 225. Asia-Pacific Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 226. Asia-Pacific Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Equipment Function, 2017-2032 (USD Million)
  • TABLE 227. Asia-Pacific Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Assembly Equipment, 2017-2032 (USD Million)
  • TABLE 228. Asia-Pacific Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Inspection & Testing Equipment, 2017-2032 (USD Million)
  • TABLE 229. Asia-Pacific Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Solution Standardization, 2017-2032 (USD Million)
  • TABLE 230. Asia-Pacific Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Automation Level, 2017-2032 (USD Million)
  • TABLE 231. Asia-Pacific Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Production Architecture, 2017-2032 (USD Million)
  • TABLE 232. Asia-Pacific Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Drug Delivery Device Type, 2017-2032 (USD Million)
  • TABLE 233. Asia-Pacific Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Parenteral Injection & Infusion Devices, 2017-2032 (USD Million)
  • TABLE 234. Asia-Pacific Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Pulmonary Inhalation Devices, 2017-2032 (USD Million)
  • TABLE 235. Asia-Pacific Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Transdermal & Intradermal Delivery Systems, 2017-2032 (USD Million)
  • TABLE 236. Asia-Pacific Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Nasal Delivery Devices, 2017-2032 (USD Million)
  • TABLE 237. Asia-Pacific Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Buyer Role, 2017-2032 (USD Million)
  • TABLE 238. Asia-Pacific Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Production Lifecycle Stage, 2017-2032 (USD Million)
  • TABLE 239. Asia-Pacific Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Line Integration, 2017-2032 (USD Million)
  • TABLE 240. Asia-Pacific Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Drug-Device Configuration, 2017-2032 (USD Million)
  • TABLE 241. Asia-Pacific Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Format Flexibility, 2017-2032 (USD Million)
  • TABLE 242. Latin America Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 243. Latin America Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Equipment Function, 2017-2032 (USD Million)
  • TABLE 244. Latin America Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Assembly Equipment, 2017-2032 (USD Million)
  • TABLE 245. Latin America Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Inspection & Testing Equipment, 2017-2032 (USD Million)
  • TABLE 246. Latin America Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Solution Standardization, 2017-2032 (USD Million)
  • TABLE 247. Latin America Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Automation Level, 2017-2032 (USD Million)
  • TABLE 248. Latin America Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Production Architecture, 2017-2032 (USD Million)
  • TABLE 249. Latin America Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Drug Delivery Device Type, 2017-2032 (USD Million)
  • TABLE 250. Latin America Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Parenteral Injection & Infusion Devices, 2017-2032 (USD Million)
  • TABLE 251. Latin America Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Pulmonary Inhalation Devices, 2017-2032 (USD Million)
  • TABLE 252. Latin America Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Transdermal & Intradermal Delivery Systems, 2017-2032 (USD Million)
  • TABLE 253. Latin America Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Nasal Delivery Devices, 2017-2032 (USD Million)
  • TABLE 254. Latin America Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Buyer Role, 2017-2032 (USD Million)
  • TABLE 255. Latin America Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Production Lifecycle Stage, 2017-2032 (USD Million)
  • TABLE 256. Latin America Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Line Integration, 2017-2032 (USD Million)
  • TABLE 257. Latin America Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Drug-Device Configuration, 2017-2032 (USD Million)
  • TABLE 258. Latin America Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Format Flexibility, 2017-2032 (USD Million)
  • TABLE 259. Middle East Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 260. Middle East Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Equipment Function, 2017-2032 (USD Million)
  • TABLE 261. Middle East Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Assembly Equipment, 2017-2032 (USD Million)
  • TABLE 262. Middle East Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Inspection & Testing Equipment, 2017-2032 (USD Million)
  • TABLE 263. Middle East Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Solution Standardization, 2017-2032 (USD Million)
  • TABLE 264. Middle East Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Automation Level, 2017-2032 (USD Million)
  • TABLE 265. Middle East Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Production Architecture, 2017-2032 (USD Million)
  • TABLE 266. Middle East Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Drug Delivery Device Type, 2017-2032 (USD Million)
  • TABLE 267. Middle East Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Parenteral Injection & Infusion Devices, 2017-2032 (USD Million)
  • TABLE 268. Middle East Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Pulmonary Inhalation Devices, 2017-2032 (USD Million)
  • TABLE 269. Middle East Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Transdermal & Intradermal Delivery Systems, 2017-2032 (USD Million)
  • TABLE 270. Middle East Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Nasal Delivery Devices, 2017-2032 (USD Million)
  • TABLE 271. Middle East Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Buyer Role, 2017-2032 (USD Million)
  • TABLE 272. Middle East Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Production Lifecycle Stage, 2017-2032 (USD Million)
  • TABLE 273. Middle East Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Line Integration, 2017-2032 (USD Million)
  • TABLE 274. Middle East Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Drug-Device Configuration, 2017-2032 (USD Million)
  • TABLE 275. Middle East Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Format Flexibility, 2017-2032 (USD Million)
  • TABLE 276. Africa Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 277. Africa Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Equipment Function, 2017-2032 (USD Million)
  • TABLE 278. Africa Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Assembly Equipment, 2017-2032 (USD Million)
  • TABLE 279. Africa Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Inspection & Testing Equipment, 2017-2032 (USD Million)
  • TABLE 280. Africa Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Solution Standardization, 2017-2032 (USD Million)
  • TABLE 281. Africa Drug Delivery Device Automated Manufacturing & Assembly Equipment Market Size, by Automation Level, 2017-2032 (USD Million)
  • TABLE 282. Africa Drug Delivery Device Automated Manufacturing & Assembly Equipment Ma